Hao-Jing Li

Multimodal AI for early lung cancer detection: from LDCT to clinical and molecular integration.

Low‑dose computed tomography (LDCT) is the established screening backbone for lung cancer in high‑risk populations. However, its clinical value depends on a complete pathway, including eligibility assessment, image acquisition, nodule interpretation, follow‑up, referral, quality assurance, and harm reduction, and not o...